The global Hormone Replacement Therapy Market demand is expected to grow 7.1% year on year to US$ 12 billion by 2032.
Hormone replacement treatment (HRT) is primarily used to treat menopausal symptoms. HRT replenishes hormones that are depleted in women as they approach menopause.
Several women have unpleasant symptoms throughout menopause, such as vaginal dryness and hot flashes. Hormone therapy, also known as menopausal hormone therapy, is an effective treatment option for menopause symptoms because it balances hormone levels in the body. Because of these causes, demand for HRT is expected to rise during the projection period.
In addition, demand for Hormone Replacement Therapy increases with growing awareness related to biological drugs for treatment of cancer. The market for biologics and protein products has developed owing to innovations in analytics observed over the past two decades.
Get Sample Report + Related Graphs & Charts@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3871
This is due to new analytical tools that enable detailed physicochemical comparisons of complex protein molecules and protein medicines. This, in turn, aids in the discovery and development of new medications and therapies.
According to FMI, the market has tremendous development potential in emerging countries such as China and India. Because of the expanding resources and big patient pool in these locations, emerging countries are focusing on strengthening their healthcare infrastructure.
Furthermore, due to a lack of numerous producers in emerging countries, vital pharmaceuticals are imported from developed regions, increasing their cost. As a result, major businesses are increasing their manufacturing capacity in order to make money from Hormone Replacement Therapy.
Key Takeaways from Market Study
- By the end of 2032, the oestrogen replacement therapy segment is predicted to account for more than 37.8% of total market value.
- By dosage type, the oral tablets/capsules sector will command more than 41.4% of the market by 2032.
- The menopause segment is expected to increase at a CAGR of 5.4% throughout the assessment period.
- In terms of market share value, hospitals held the greatest segment share of 55.3% in 2021.
- Because of the greater number of CROs and CMOs in the US, North America is regarded the leading region, with a value share of 30.1% by the end of the prediction period.
“With increasing prevalence of autoimmune disorders and expenditure to accelerate R&D activities, the Hormone Replacement Therapy market is expected to witness advancements over the forecast period,” says an analyst of Future Market Insights.
To remain ‘ahead’ of your competitors, Ask a Question@ https://www.futuremarketinsights.com/ask-question/rep-gb-3871
Market Competition
Companies are adopting strategies such as mergers and acquisitions to gain competitive edge. Leading manufacturers such as Eli Lilly and Company, AbbVie, and Endo International plc are also adopting these strategies to enhance their presence in the market
For instance:
- Eli Lilly and Company bought Protomer Technologies in July 2021 to develop and synthesise molecules capable of sensing glucose or other endogenous modulators of protein activity.
- Following regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court, AbbVie bought Allergan plc in May 2020.
- Endo International plc bought BioSpecifics Technologies Corp., a commercial-stage biopharmaceutical business, in December 2020.
A list of Key Players Covered in the Hormone Replacement Therapy Market Are:
Eli Lilly and Company, Pfizer, Inc., AbbVie, Inc., Novo Nordisk A/S, Merck KGaA, Mylan N.V., Bayer Healthcare, F. Hoffmann-La Roche Ltd., Teva Pharmaceuticals, Endo International, Sun Pharmaceutical Industries Ltd, Tolmar Pharmaceuticals, Inc., Novartis AG, Upsher-Smith Laboratories Inc., SottoPelle, Neuva Aesthetics, Ascend Therapeutics
Want more insights?
Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032.
For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/3871
Hormone Replacement Therapy Market: Segmentation
Based on Therapy Type:
- Estrogen Replacement Therapy
- Growth Hormone Replacement
- Dopamine Agonist
- Somatostatin Analogues
- Thyroid Hormone Replacement
- Tablets
- Capsules
- Injections
Based on Application:
- Cancer
- Menopause
- Hypopituitarism
- Hypothyroidism
- Others
Based on Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies and Drugstores
- Compounding Pharmacies
- E-commerce
- Others
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs